货号:A274351 同义名: 非布索坦 / TEI 6720;TMX 67
Febuxostat is an inhibitor of xanthine oxidase with Ki of 0.6 nM and can affect the progression of renal disease.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Xanthine oxidase (XO) is catalyzes the two terminal reactions in uric acid synthesis. The inhibitors of this enzyme have been used in the treatment of hyperuricemia and gout. Febuxostat is a non-purine inhibitor of XO that shows potent inhibition of purified bovine milk XO with Ki and Ki’ values of 0.6 and 3.1nM, respectively, indicating that febuxostat was able to inhibit both oxidized and reduced forms of XO[6]. In Sprague–Dawley rats with renal ischemia–reperfusion (I/R) injury, pretreatment of febuxostat (10 mg/kg) significantly decreased UA levels (0.3mg/dL) compared with vehicle-treated group (1.4mg/dL) 4h after the injury. Also, the concentration of a nitro-oxidative stress marker, nitrotyrosine, in febuxostat-treated I/R-injured kidneys was lower (11.9pmol/g tissue) than that from control kidney (30.7pmol/g tissue) 4h post disease induction. Febuxostat also significantly reduced TBARS concentration (28.5nmol/g tissue) compared with vehicle-treated animals (37.6nmol/g tissue). In addition, febuxostat ameliorated the induced serum UN and creatinine levels, which was seen in the control group. After the injury, the number of ED-1 positive macrophages was significantly increased in interstitial area of kidneys at 24h and 72h, while febuxostat prevented the infiltration of ED-1-positive macrophages[7]. |
作用机制 | Febuxostat exerts potent mixed-type inhibition of XO by the high-affinity binding to the enzyme in a molecular channel leading to the molybdenum-pterin active site[8]. |
Dose | Rat: 1 mg/kg - 10 mg/kg[3] (p.o.) Mice: 1 mg/kg, 5 mg/kg[4] (p.o.) | ||||||||||||
Administration | p.o. | ||||||||||||
Pharmacokinetics |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03691688 | - | Recruiting | March 1, 2022 | China, Shanghai ... 展开 >> Shanghai Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Shalaimaiti Shali, MD 86+13761553110 shali@zs-hospital.sh.cn Contact: Yuxiang Dai, MD,PhD +86-13818988550 dai.yuxiang@zs-hospital.sh.cn Principal Investigator: Junbo Ge, Professor 收起 << | |
NCT01361646 | Hyperuricemia ... 展开 >> Gout 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT01508702 | Gout | Phase 3 | Completed | - | - |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.16mL 0.63mL 0.32mL |
15.80mL 3.16mL 1.58mL |
31.61mL 6.32mL 3.16mL |
CAS号 | 144060-53-7 |
分子式 | C16H16N2O3S |
分子量 | 316.37 |
别名 | 非布索坦 ;TEI 6720;TMX 67;Adenuric;Uloric;FBX |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,Room Temperature |
溶解度 |
DMSO: 50 mg/mL(158.04 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |